'Sun Pharma Shares' - 77 News Result(s)

  • Sensex Edges Down in Cautious Trade; Sun Pharma Rises
    Sensex Edges Down in Cautious Trade; Sun Pharma Rises

    Shares have retreated since hitting record highs early this month, as analysts warned about waning momentum and low trading volumes ahead of the end of the fiscal year at the end of March.

  • Sun Pharma Gets RBI Nod for Transfer of Ranbaxy Overseas Investments
    Sun Pharma Gets RBI Nod for Transfer of Ranbaxy Overseas Investments

    Sun Pharmaceutical Industries has received approval from the Reserve Bank of India (RBI) for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of the $4-billion merger deal b...

  • Sun Pharma, Ranbaxy, JSPL in Focus Today
    Sun Pharma, Ranbaxy, JSPL in Focus Today

    The Nifty opened flat on Tuesday. However, sentiment is likely to be positive as both foreign and domestic investors turned net buyers of Indian equities on Monday. Foreign investors bought shares worth Rs 417 crore while, domestic investors were net...

  • Why SPARC Shares Surged Over 40% in March
    Why SPARC Shares Surged Over 40% in March

    The trading volumes in the month so far has been very high; on Monday as many as 6 million shares of SPARC changed hands on the BSE.

  • Dilip Shanghvi Overtakes Mukesh Ambani as Richest Indian: Forbes
    Dilip Shanghvi Overtakes Mukesh Ambani as Richest Indian: Forbes

    Pharmaceuticals tycoon Dilip Shanghvi has surpassed Mukesh Ambani as the world's richest Indian with a net worth of $21.5 billion (Rs 1.33 lakh crore at 1 dollar = 62 rupees) - within two days of the Reliance Industries chief being ranked India's wea...

  • US Regulator Raises Concerns on Waluj Plant: Wockhardt
    US Regulator Raises Concerns on Waluj Plant: Wockhardt

    Shares in Wockhardt Ltd fell as much as 5.3 per cent on Thursday after the drug maker said the US Food and Drug Administration (FDA) had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.

  • Suzlon Soars 20% as Dilip Shanghvi Buys Stake
    Suzlon Soars 20% as Dilip Shanghvi Buys Stake

    Shares in Suzlon Energy jumped over 18 per cent on Monday after the debt-laden turbine maker got an investor in the form of Sun Pharma's billionaire promoter Dilip Shanghvi.

  • Sun Pharma Founder's Wife Gets Rs 280 Crore Shares in Gift
    Sun Pharma Founder's Wife Gets Rs 280 Crore Shares in Gift

    Sun Pharma founder Dilip Shanghvi's mother Kumud has gifted nearly 31 lakh shares in the drugmaker to her daughter-in-law Vibha, according to a regulatory filing on the Bombay Stock Exchange. The transfer took place on January 30 and is valued at Rs ...

  • Sun Pharma, Ranbaxy Hit 52-Week Highs on Merger Nod
    Sun Pharma, Ranbaxy Hit 52-Week Highs on Merger Nod

    Shares of Sun Pharma jumped as much as 3 per cent to a hit new 52-week high of Rs 943. Ranbaxy also jumped as much as 3.6 per cent to hit its new 52-week high of Rs 728.

  • Ranbaxy, TVS Motor, SRF in Focus Today
    Ranbaxy, TVS Motor, SRF in Focus Today

    The Nifty opened higher on Friday as indicated by futures trade on Singapore Stock Exchange. Both foreign and domestic investors turned net buyers of Indian equities on Thursday but with low intensity. Foreign investors bought shares worth Rs 18 cror...

  • Sensex Turns Negative, Nifty Falls Below 8,300
    Sensex Turns Negative, Nifty Falls Below 8,300

    Shares in oil explorers continued to drag the benchmark indices further. Cairn India fell nearly 3 per cent, while ONGC was down over 2 per cent amid margin concerns on account of falling crude oil prices. GAIL India slumped nearly 4 per cent to be t...

  • Sensex Falls Over 200 Points, Metal Stocks Drag
    Sensex Falls Over 200 Points, Metal Stocks Drag

    Market breadth turned negative as 920 stocks out of the 2,751 shares traded on BSE advanced and 1,738 stocks declined.

  • Sun Pharma, Ranbaxy, OnMobile Global in Focus Today
    Sun Pharma, Ranbaxy, OnMobile Global in Focus Today

    The Nifty opened lower on Tuesday tracking a sell-off in the global market. However Brent crude price, which fell to a fresh five-year low, is likely to keep sentiments positive today. Foreign investors remained net buyers to the tune of Rs 4,985 cro...

  • SBI, Tata Motors, Sun Pharma in Focus Today
    SBI, Tata Motors, Sun Pharma in Focus Today

    The Nifty opened higher on Friday as indicated by futures trade on Singapore Stock Exchange. Foreign investors continued to remain net buyers of Indian equities as they had bought shares worth Rs 691 crore in cash market in Thursday. However domestic...

  • Sun Pharma, Tata Steel, Eicher Motors in Focus Today
    Sun Pharma, Tata Steel, Eicher Motors in Focus Today

    The Nifty opened higher on Thursday as indicated by futures trade on Singapore Stock Exchange. Foreign investors continued to be net buyers of Indian equities as they have bought shares worth Rs 459 crore in cash market on Wednesday. However domestic...

  • Ranbaxy Shares Fall 5% on US FDA Blow
    Ranbaxy Shares Fall 5% on US FDA Blow

    Analysts had expected generic Nexium to contribute about $150 million to Ranbaxy's sales in the first six months of the exclusive sales period, while Valcyte was expected to contribute between $40 million and $50 million.

  • Ranbaxy, Sun Pharma, Hero MotoCorp in Focus Today
    Ranbaxy, Sun Pharma, Hero MotoCorp in Focus Today

    The Nifty opened lower on Friday as indicated by futures trade on Singapore Stock Exchange. Foreign investors continued to remain net buyers of Indian equities on Wednesday as they had bought shares worth Rs 1,031 crore in the cash market. However do...

  • Next Generation Business Leaders' Stock Wealth Rises in Market Rally
    Next Generation Business Leaders' Stock Wealth Rises in Market Rally

    As the record stock market rally continues, the value of shares directly owned by next-generation business leaders at 20 major corporate houses has soared over 18 per cent to Rs 17,000 crore so far this year.

  • Sun Pharma, Voltas Gain Amid Huge Volume
    Sun Pharma, Voltas Gain Amid Huge Volume

    Sun Pharma gained over 4 per cent on Friday with around 185 per cent jump in its delivery volume to 48.19 lakh shares. Total volume in the stock also increased 236 per cent over its last ten day's average volume to 1 crore shares on Friday.

  • Pharma Shares Gain as Government Curbs Regulator's Power
    Pharma Shares Gain as Government Curbs Regulator's Power

    NPPA had capped prices of 108 non-essential drugs in July to improve its affordability, but the decision was greeted with protests and has been challenged in courts in India as prices of generic drugs are already low in India compared with other mark...

Advertisement

Advertisement

Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2015. All rights reserved.